Celiac Disease-associated Neisseria Flavescens Decreases Mitochondrial Respiration in CaCo-2 Epithelial Cells: Impact of Lactobacillus Paracasei CBA L74 on Bacterial-induced Cellular Imbalance
Overview
Microbiology
Authors
Affiliations
We previously identified a Neisseria flavescens strain in the duodenum of celiac disease (CD) patients that induced immune inflammation in ex vivo duodenal mucosal explants and in CaCo-2 cells. We also found that vesicular trafficking was delayed after the CD-immunogenic P31-43 gliadin peptide-entered CaCo-2 cells and that Lactobacillus paracasei CBA L74 (L. paracasei-CBA) supernatant reduced peptide entry. In this study, we evaluated if metabolism and trafficking was altered in CD-N. flavescens-infected CaCo-2 cells and if any alteration could be mitigated by pretreating cells with L. paracasei-CBA supernatant, despite the presence of P31-43. We measured CaCo-2 bioenergetics by an extracellular flux analyser, N. flavescens and P31-43 intracellular trafficking by immunofluorescence, cellular stress by TBARS assay, and ATP by bioluminescence. We found that CD-N. flavescens colocalised more than control N. flavescens with early endocytic vesicles and more escaped autophagy thereby surviving longer in infected cells. P31-43 increased colocalisation of N. flavescens with early vesicles. Mitochondrial respiration was lower (P < .05) in CD-N. flavescens-infected cells versus not-treated CaCo-2 cells, whereas pretreatment with L. paracasei-CBA reduced CD-N. flavescens viability and improved cell bioenergetics and trafficking. In conclusion, CD-N. flavescens induces metabolic imbalance in CaCo-2 cells, and the L. paracasei-CBA probiotic could be used to correct CD-associated dysbiosis.
L-Arginine supplementation as mitochondrial therapy in diabetic cardiomyopathy.
Fiordelisi A, Cerasuolo F, Avvisato R, Buonaiuto A, Maisto M, Bianco A Cardiovasc Diabetol. 2024; 23(1):450.
PMID: 39707340 PMC: 11662564. DOI: 10.1186/s12933-024-02490-x.
Postbiotics: As a Promising Tools in the Treatment of Celiac Disease.
Khani N, Bonyadi M, Soleimani R, Raziabad R, Ahmadi M, Homayouni-Rad A Probiotics Antimicrob Proteins. 2024; .
PMID: 39673575 DOI: 10.1007/s12602-024-10416-y.
Zeng L, Yang K, He Q, Zhu X, Long Z, Wu Y BMC Med. 2024; 22(1):110.
PMID: 38475833 PMC: 10935932. DOI: 10.1186/s12916-024-03303-4.
Celiac disease: Pathogenesis, disease management and new insights into the herbal-based treatments.
Mittal P, Arora D, Parashar S, Goyal R, Khan A, Chopra H Narra J. 2024; 3(2):e147.
PMID: 38454981 PMC: 10919711. DOI: 10.52225/narra.v3i2.147.
Furone F, Bellomo C, Carpinelli M, Nicoletti M, Hewa-Munasinghege F, Mordaa M Front Med (Lausanne). 2023; 10:1085578.
PMID: 37215707 PMC: 10192745. DOI: 10.3389/fmed.2023.1085578.